Search…

Lates News

27/09/2025

Pharmaceutical company Crinetics Pharmaceuticals soared 26.6% in early trading, receiving approval from the US FDA for its treatment drug Palsonify for acromegaly. The approval was based on successful phase three trials, and the product is scheduled to be launched in early October. This marks an important milestone for Crinetics in the field of rare disease treatment.

Latest

7 m ago

Bauman: Stubborn and dogmatic attention to recent data is a mistake, as it will lead to a retrospective thinking of the economy and keep us behind.

9 m ago

Federal Reserve's Bowman: Selling mortgage-backed securities should be considered. The Fed's emergency tools should not be permanent; Inflation is expected to return to the 2% target after a one-time tariff adjustment.

10 m ago

Rescue workers have located and rescued one trapped individual in the Shanxi Zhenping coal mine collapse accident, but the individual shows no signs of life.

11 m ago

International copper night session fell by 0.75%, Shanghai copper fell by 0.79%, Shanghai aluminum fell by 0.55%, Shanghai zinc fell by 1.50%, Shanghai lead fell by 0.09%, Shanghai nickel fell by 0.86%, and Shanghai tin fell by 0.12%. Aluminum oxide night session fell by 1.68%, aluminum alloy fell by 0.64%. Stainless steel night session fell by 0.66%.

11 m ago

Baumann: We should take decisive action now to protect employment.

See all latest